FDA recall record

Pharma-Natural Pharma Natural, Biotin 5000 mcg, Maximum Strength, Dietary recall — FDA F-1615-2023

FDA sample analysis of Pharma Natural Biotin 5000 mcg Maximum Strength (30 tablets, Lot: PN10686, Exp. Date 01/24), found the biotin content was below the…

Class IIIclassification
F-1615-2023official record ID
Oct 4, 2023report date

Recall record at a glance

Official recordF-1615-2023
CategoryFood Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmPharma-Natural Inc.
Report dateOct 4, 2023
Recall initiation dateAug 15, 2023
Quantity204 bottles (102 twin packs)/30 tablets per bottle
LocationMiami Lakes, FL, United States

Official product description

Pharma Natural, Biotin 5000 mcg, Maximum Strength, Dietary Supplement, 30 Tablets

Why the product was recalled

FDA sample analysis of Pharma Natural Biotin 5000 mcg Maximum Strength (30 tablets, Lot: PN10686, Exp. Date 01/24), found the biotin content was below the detection limit.

Distribution information

Puerto Rico

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

DrugJul 31, 2019

GENCONTUSS recall — FDA D-1497-2019

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Class IIFDA: TerminatedPharma-Natural Inc.
DrugJul 31, 2019

Pharma-Natural DOUBLE TUSSIN DM recall — FDA D-1498-2019

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Class IIFDA: TerminatedPharma-Natural Inc.
DrugJul 31, 2019

Pharma-Natural AbeeMed cream recall — FDA D-1493-2019

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Class IIFDA: TerminatedPharma-Natural Inc.